Rheumatoid Arthritis

Guidelines for Biosimilar Use for Treatment of Rheumatologic Diseases

Guidelines for Biosimilar Use for Treatment of Rheumatologic Diseases

By

Consensus recommendations on the use of biosimilars for the treatment of patients with rheumatologic diseases were recently published in Annals of the Rheumatic Diseases.

Ketoprofen Safe, Effective Pain Management for Rheumatoid Arthritis

Ketoprofen Safe, Effective Pain Management for Rheumatoid Arthritis

By

Ketoprofen was found to be effective in relieving moderate to severe pain in patients with rheumatoid arthritis.

Safety Guidelines Issued for Use of RA Drugs During Pregnancy and Lactation

Safety Guidelines Issued for Use of RA Drugs During Pregnancy and Lactation

By

Although a majority of women with rheumatoid arthritis were previously though to achieve remission during pregnancy, recent studies indicate remission occurs in only 20% to 40% of cases.

Vitamin D Deficiency Associated With Neuropathic Pain in Rheumatoid Arthritis

Vitamin D Deficiency Associated With Neuropathic Pain in Rheumatoid Arthritis

By

In patients with rheumatoid arthritis, vitamin D deficiency was shown to be associated with increased neuropathic pain.

Tocilizumab Linked to Anemia Marker Improvement in Rheumatoid Arthritis

Tocilizumab Linked to Anemia Marker Improvement in Rheumatoid Arthritis

By

Tocilizumab was associated with significant improvements in hemoglobin and hematocrit over 2 years of treatment in patients with rheumatoid arthritis.

Morphine Lacks Efficacy for RA, Chronic Fatigue Syndrome and Fibromyalgia

Morphine Lacks Efficacy for RA, Chronic Fatigue Syndrome and Fibromyalgia

For patients with chronic fatigue syndrome/fibromyalgia or rheumatoid arthritis, morphine has anti-hyperalgesic effects comparable with placebo.

Methotrexate Response in RA may be Predicted by Gene Expression

Methotrexate Response in RA may be Predicted by Gene Expression

Increased baseline gene expression in peripheral blood may be associated with improved clinical response to methotrexate in rheumatoid arthritis.

Disease Activity on Foot MRI Despite Clinical Remission in Rheumatoid Arthritis

Disease Activity on Foot MRI Despite Clinical Remission in Rheumatoid Arthritis

By

A sizeable percentage of patients with rheumatoid arthritis who are in clinical remission have evidence of disease activity on magnetic resonance imaging of the foot that is mostly affected.

Opioid Use Patterns in Rheumatoid Arthritis

Opioid Use Patterns in Rheumatoid Arthritis

By

Longitudinal opioid prescribing patterns suggest that regular use among patients with rheumatoid arthritis (RA) is slightly declining.

Sirukumab Improves Depression in Patients With Rheumatoid Arthritis

Sirukumab Improves Depression in Patients With Rheumatoid Arthritis

By

Peripheral anti-IL-6 cytokine treatment is associated with improvement in depressive symptoms in patients with RA.

Diagnostic Value of MRI for Unclassified Arthritis

Diagnostic Value of MRI for Unclassified Arthritis

MRI may assist in identifying patients with unclassified arthritis who will develop rheumatoid arthritis (RA) — primarily in patients with UA presenting with oligoarthritis.

Low Disease Activity in Rheumatoid Arthritis After Tofacitinib Discontinuation

Low Disease Activity in Rheumatoid Arthritis After Tofacitinib Discontinuation

By

Approximately 1 in 3 patients with RA who discontinued tofacitinib maintained low disease activity after 1 year.

Testing Patients With Rheumatoid Arthritis for Metabolic Syndrome

Testing Patients With Rheumatoid Arthritis for Metabolic Syndrome

By

A high prevalence and risk for metabolic syndrome was found in patients with rheumatoid arthritis.

Remicade Biosimilar FDA-Approved

Remicade Biosimilar FDA-Approved

By

The FDA has approved Renflexis, the second approved biosimilar to Remicade.

Rheumatoid Arthritis Patients More Affected by <i>Staphylococcus aureus</i> Infections

Rheumatoid Arthritis Patients More Affected by Staphylococcus aureus Infections

By

Patients with RA suffering from S. aureus infection have more complications and higher mortality rates than patients without RA.

DMARDs Rheumatoid Arthritis Treatment Guidelines Updated

DMARDs Rheumatoid Arthritis Treatment Guidelines Updated

By

EULAR recommendations were updated for rheumatoid arthritis management to include new guidelines on starting effective therapy in patients early.

Tocilizumab and Cardiovascular Risk in RA Patients

Tocilizumab and Cardiovascular Risk in RA Patients

No evidence was found of a higher cardiovascular risk among rheumatoid arthritis patients who switched from a different biologic drug or tofacitinib to tocilizumab vs to a tumor necrosis factor inhibitor.

Developing Biomarkers for Inflammatory Arthritis

Developing Biomarkers for Inflammatory Arthritis

By

Urinary proteomics may help identify biomarkers that can distinguish between different types of inflammatory arthritis.

Parameters of Clinically Suspect Arthralgia According to EULAR

Parameters of Clinically Suspect Arthralgia According to EULAR

Early identification and treatment of patients with RA is central to successfully limiting joint damage and disease progression.

Bridging Gaps in Patient Access to Rheumatologists With Telemedicine

Bridging Gaps in Patient Access to Rheumatologists With Telemedicine

By

Telerheumatology can improve healthcare access, patient outcomes, and costs

Rheumatoid, IBD Treatments and Risk of Breast Cancer Recurrence

Rheumatoid, IBD Treatments and Risk of Breast Cancer Recurrence

No statistically significant association was found between MTX or anti-TNF use and breast cancer recurrence.

Association Between Cortical Thickness and Pain Duration

Association Between Cortical Thickness and Pain Duration

By

Knee OA was associated with cortical thinning in brain regions not typically associated with pain processing.

Biomarker Profiles Improve RA Relapse Predictions During DMARD Taper

Biomarker Profiles Improve RA Relapse Predictions During DMARD Taper

By

MBDA scores combined with ACPA testing allowed researchers to predict RA relapse in more than 80% of patients.

Depression, Anxiety Compared in Chronic Pain and Rheumatoid Arthritis Patient Populations

Depression, Anxiety Compared in Chronic Pain and Rheumatoid Arthritis Patient Populations

"Based on our 2 study populations, individuals with chronic pain experienced more severe depressive, anxiety, and stress symptoms compared to those with chronic RA."

Inflammatory Joint Signs Increased by Smoking in Relatives of RA Patients

Inflammatory Joint Signs Increased by Smoking in Relatives of RA Patients

By

Age and cigarette smoking are associated with inflammatory joint signs in a high-risk cohort of RA first-degree relatives.

The Short-Form Health Survey as an Effective Diagnostic Tool for Psychiatric Comorbidities in RA Patients

The Short-Form Health Survey as an Effective Diagnostic Tool for Psychiatric Comorbidities in RA Patients

The analysis found that the SF-36 survey was an effective diagnostic tool for MDD and GAD in patients with RA.

Lowering Rheumatoid Arthritis Risk in Highly Susceptible Populations Through Patient Education

Lowering Rheumatoid Arthritis Risk in Highly Susceptible Populations Through Patient Education

By

Assessing epidemiologic and genetic factors among individuals with positive family history of RA may identify those suitable for RA prevention strategies

Rheumatoid Arthritis: Different Mechanisms for Different Joints

Rheumatoid Arthritis: Different Mechanisms for Different Joints

By

The heterogeneity of RA pathologic processes renders development of adapted treatments challenging, calling for a better understanding of location-specific disease mechanisms.

Can Tocilizumab Treat RA After Non-TNFi Failure?

Can Tocilizumab Treat RA After Non-TNFi Failure?

Better efficacy for tocilizumab versus abatacept and rituximab in patients with first non-TNFi failure.

Is RA Among Preop Predictors of Hospital Readmission Following THR?

Is RA Among Preop Predictors of Hospital Readmission Following THR?

The use of a postoperative risk stratification model can serve to reduce the costs associated with hospital readmission by identifying patients with specific risk factors.

Sign Up for Free e-Newsletters